Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Annals of the Rheumatic Diseases

Ab0927 Serum Interleukin-40 Levels in Patients With Inflammatory Bowel Diseases-Associated Spondyloarthritis: A Preliminary Study

View Full Paper
Ask AI
Bookmark
Share

Authors

LOL. OndrejčákováANA. NavrátilováMGMonika Gregová

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ondrejčáková et al. (2024) studied this question.

synapsesocial.com/papers/68e66db9b6db6435875f8767https://doi.org/10.1136/annrheumdis-2024-eular.5225
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1AB1160 IL-40 ELEVATION IN SYSTEMIC SCLEROSIS: UNRAVELLING A LINK TO DISEASE ACTIVITY, GASTROINTESTINAL INVOLVEMENT, IMMUNE REGULATION AND FIBROTIC PROCESSES2024
  2. 2Interleukin‐40 in Systemic Sclerosis: A Treatment‐Sensitive Marker of Immune Modulation Rather Than Disease Activity2026 · 1 citations
  3. 3<scp>IL40</scp> : A Newly Described Cytokine With Conflicting Measurements and Detection Variability—Are There Different Forms?2026
  4. 4IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro2024 · 12 citations
  5. 5IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis2021 · 46 citations